TCTR20220712001已完成不适用
Immunogenicity in previously vaccinated adults after COVID-19 infection
Ratchadapiseksompotch Research Fund0 个研究点目标入组 88 人开始时间: 2022年7月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1. 18-60 years old
- •2. Can comply with the trial
- •3. Either had been infected with COVID-19 after vaccination or had a booster dose of vaccination
排除标准
- •1. Received any other vaccines within 4 months prior
- •2. Received blood or blood product or immunoglobulin within 3 months
- •3. In a high-level immunosuppression stage
- •4. Received monoclonal antibody, JAK inhibitor or convalescent plasma for COVID-19
研究者
相似试验
进行中（未招募）
不适用
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous DoseActive immunization against tetanus, diphtheria and pertussisMedDRA version: 18.1Level: PTClassification code 10054129Term: Diphtheria immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: PTClassification code 10069577Term: Pertussis immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 18.1Level: PTClassification code 10054131Term: Tetanus immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2015-005842-69-Outside-EU/EEASanofi Pasteur Limited789
进行中（未招募）
1 期
Immunological responses after concomitant vaccination with the yellow fever-vaccine and the TBE-vaccine, or JE-vaccinePrevention of TBE or Japanece encephalitis by co-vaccination with the yellow fever vaccineEUCTR2017-002137-32-SEHans-Gustaf Ljunggren140
进行中（未招募）
不适用
A study of the immune response to vaccination in MS patients treated with alemtuzumab - CAM-VACThe vaccinations are being used to investigate immunological memory following treatment of multiple sclerosis with the lympho-depleting humanised monoclonal antibody alemtuzumab.MedDRA version: 9.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisMedDRA version: 9.1Level: PTClassification code 10063400Term: Secondary progressive multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10046859Term: VaccinationEUCTR2009-011523-31-GBR & D, Cambridge University Hospitals60
进行中（未招募）
不适用
Etude des réponses immunitaires après vaccination anit-influenza saisonnier et anti-H1N1 variant pandémique dans une population de personnel soignant. - FLU-HOPsymptome de la grippeMedDRA version: 12.0Level: LLTClassification code 10016797Term: Flu-like symptomsEUCTR2009-016267-11-FRInserm
招募中
不适用
Evaluation of antibody production after vaccination with COVID-19 in volunteer donorsJPRN-jRCT1071210129Kawasaki Tatsuhiko30